Dean Crowe: Advancing the Fight for Childhood Cancer Research
The Citizen highlighted Rally Foundation for Childhood Cancer Research’s ongoing efforts to advance research for DIPG and DMG, two aggressive pediatric brain cancers. The article features Rally CEO and Founder Dean Crowe, who discusses the urgent need for new treatment options and Rally’s commitment to funding innovative research. Rally has supported 13 research projects focused on DIPG/DMG, helping researchers explore new approaches beyond traditional radiation and work toward more effective treatments for children facing these devastating cancers.